MEDGF OTC
Medacta Group S.A.
1W: +0.0%
1M: -14.1%
3M: +63.9%
YTD: +63.9%
1Y: +63.9%
3Y: +66.6%
5Y: +14.1%
$137.50
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$688M
+16.5% ▲
5Y CAGR: +17.9%
Gross Profit
$441M
+10.5% ▲
5Y CAGR: +15.5%
Operating Income
$116M
+27.3% ▲
5Y CAGR: +18.5%
Net Income
$96M
+31.8% ▲
5Y CAGR: +21.0%
EPS (Diluted)
$4.81
+31.8% ▲
5Y CAGR: +21.1%
EBITDA
$190M
+18.7% ▲
5Y CAGR: +18.4%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $363M | $437M | $511M | $591M | $688M |
| YoY Growth | +20.0% | +20.4% | +16.9% | +15.6% | +16.5% |
| Cost of Revenue | $102M | $132M | $163M | $191M | $247M |
| Gross Profit | $261M | $305M | $348M | $399M | $441M |
| Gross Margin | 71.9% | 69.8% | 68.1% | 67.6% | 64.1% |
| R&D Expenses | $11M | $16M | $20M | $21M | $0 |
| SG&A Expenses | $182M | $220M | $252M | $232M | $0 |
| Operating Expenses | $203M | $244M | $273M | $309M | $326M |
| Operating Income | $59M | $61M | $74M | $91M | $116M |
| Operating Margin | 16.2% | 14.1% | 14.6% | 15.4% | 16.8% |
| Interest Expense | $3M | $4M | $7M | $8M | $7M |
| Income Before Tax | $55M | $55M | $59M | $88M | $116M |
| Tax Expense | $4M | $9M | $11M | $15M | $20M |
| Net Income | $52M | $46M | $47M | $73M | $96M |
| Net Margin | 14.2% | 10.6% | 9.3% | 12.3% | 14.0% |
| EPS (Diluted) | $2.58 | $2.31 | $2.37 | $3.65 | $4.81 |
| EBITDA | $98M | $107M | $120M | $161M | $190M |
| Shares Outstanding | 20M | 20M | 20M | 20M | 20M |